Results 261 to 270 of about 54,210 (294)
Some of the next articles are maybe not open access.
Primary amyloidosis (AL) in families
American Journal of Hematology, 1986AbstractWe report the occurrence of immunoglobulin‐related amyloidosis (AL) in three separate families, each family having two members affected. None of the six patients had evidence to suggest the presence of familial amyloidosis (AF). Previously, immunoglobulin‐related amyloidosis (AL) was considered to be a sporadic disease process.
M A, Gertz, J P, Garton, R A, Kyle
openaire +2 more sources
Management of AL amyloidosis in 2021+
Amyloid, 2021Pallidini et al. in their review article ‘Management of AL Amyloidosis in 2020’ detail the therapeutic options for patients with this disorder [1].
openaire +2 more sources
The epidemiology of AL and AA amyloidosis
Baillière's Clinical Rheumatology, 1994The limited available epidemiological information on AL amyloidosis suggests that there may be differences between population-based studies and case series data with respect to variables such as age and racial patterns. Much more work in this area is required before specific aetiologic hypotheses can be tested.
R W, Simms, M N, Prout, A S, Cohen
openaire +2 more sources
Revue medicale de Bruxelles, 2001
AL amyloidosis is a systemic disease caused by the deposition of fibrillar proteins in organs and tissues. These deposits are responsible for organic dysfunctions and may be rapidly lethal. Current therapy is unsatisfactory. We describe three clinical cases of multisystemic AL amyloidosis but with different initial presentation: nephrotic syndrome ...
A R, Hedeshi +6 more
openaire +1 more source
AL amyloidosis is a systemic disease caused by the deposition of fibrillar proteins in organs and tissues. These deposits are responsible for organic dysfunctions and may be rapidly lethal. Current therapy is unsatisfactory. We describe three clinical cases of multisystemic AL amyloidosis but with different initial presentation: nephrotic syndrome ...
A R, Hedeshi +6 more
openaire +1 more source
Nihon rinsho. Japanese journal of clinical medicine, 1995
AL amyloidosis is one type of systemic amyloidosis. AL represents Amyloid of Light chains (of Ig's) type. Diagnosis of amyloid must be carried out by patho-histological Congo-red stains of the biopsied materials under suspicion of amyloid deposits from patients with various clinical manifestations, including macroglossia, cardiac abnormalities, ECG ...
openaire +1 more source
AL amyloidosis is one type of systemic amyloidosis. AL represents Amyloid of Light chains (of Ig's) type. Diagnosis of amyloid must be carried out by patho-histological Congo-red stains of the biopsied materials under suspicion of amyloid deposits from patients with various clinical manifestations, including macroglossia, cardiac abnormalities, ECG ...
openaire +1 more source
Prevalence and clinical outcomes of transthyretin amyloidosis: a systematic review and meta‐analysis
European Journal of Heart Failure, 2022Alexios S Antonopoulos +2 more
exaly
Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis
Circulation Research, 2021Jan M Griffin +2 more
exaly